A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

被引：0
|
作者：
William Schelman
Sherry Morgan-Meadows
Howard Bailey
Kyle Holen
James P. Thomas
Jens Eickhoff
Heidi Brandon
Kate Oliver
Dona Alberti
George Wilding
机构：
[1] University of Wisconsin Paul P. Carbone Comprehensive Cancer Center,
[2] Southern Cancer Center,undefined
[3] The Ohio State University Comprehensive Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Gemcitabine; Patupilone; Chemotherapy; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 733
页数：6
相关论文
共 50 条
  • [31] Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2)
    Rinaldi, DA
    Lormand, NA
    Brierre, JE
    Cole, JL
    Stagg, MP
    Fontenot, AF
    Buller, EJ
    Rainey, JM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 523 - 527
  • [32] Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients
    Nemunaitis, J
    Cunningham, CC
    Vukelja, S
    Ruxer, RL
    Adams, N
    Rich, D
    Paulson, AS
    MacEachern, JB
    CANCER INVESTIGATION, 2004, 22 (03) : 360 - 367
  • [33] A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors
    Hensley, Martee L.
    Dizon, Don
    Derosa, Felicia
    Venkatraman, Ennapadam
    Sabbatini, Paul
    Chi, Dennis S.
    Dupont, Jakob
    Colevas, A. Dimitrios
    Spriggs, David
    Aghajanian, Carol
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (04) : 335 - 341
  • [34] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Serna, Derek S.
    Bekaii-Saab, Tanios
    Kraut, Eric H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1390 - 1394
  • [35] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Derek S. Serna
    Tanios Bekaii-Saab
    Eric H. Kraut
    Investigational New Drugs, 2011, 29 : 1390 - 1394
  • [36] A phase I trial of docetaxel and gemcitabine in patients with advanced cancer
    Rischin, D
    Boyer, M
    Smith, J
    Millward, M
    Michael, M
    Bishop, J
    Zalcberg, J
    Davison, J
    Emmett, E
    McClure, B
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 421 - 426
  • [37] A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors
    Fountzilas, Christos
    Adjei, Alex
    Opyrchal, Mateusz
    Evans, Rachel
    Ghasemi, Mohammad
    Attwood, Kristopher
    Groman, Adrienne
    Bshara, Wiam
    Goey, Andrew
    Wilton, John
    Ma, Wen Wee
    Iyer, Renuka
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (12) : 2063 - 2074
  • [38] Phase I trial of gemcitabine in patients with advanced pancreatic cancer
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Furuse, J
    Maru, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 7 - 12
  • [39] A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors
    Martee L. Hensley
    Don Dizon
    Felicia Derosa
    Ennapadam Venkatraman
    Paul Sabbatini
    Dennis S. Chi
    Jakob Dupont
    A. Dimitrios Colevas
    David Spriggs
    Carol Aghajanian
    Investigational New Drugs, 2007, 25 : 335 - 341
  • [40] A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy
    Pishvaian, Michael J.
    Slack, Rebecca
    Koh, Eunice Y.
    Beumer, Jan H.
    Hartley, Marion L.
    Cotarla, Ion
    Deeken, John
    He, Aiwu Ruth
    Hwang, Jimmy
    Malik, Shakun
    Firozvi, Kashif
    Liu, Minetta
    Elston, Beth
    Strychor, Sandy
    Egorin, Merrill J.
    Marshall, John L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 843 - 853
12345